FLJ30851 inhibitors are a class of chemical compounds designed to target and inhibit the function of the FLJ30851 gene or its associated protein products. FLJ30851 is an identifier for a gene that encodes a protein involved in a variety of cellular processes, although the specific functions and interactions of this protein may be dependent on the cellular context. Inhibitors of FLJ30851 are typically small molecules or biologics that bind to the active sites or regulatory domains of the protein encoded by this gene. By inhibiting the function of FLJ30851, these compounds can interfere with cellular pathways that rely on the protein for regulatory functions, potentially altering transcriptional, translational, or signaling events within the cell. The mechanisms of inhibition can vary depending on the structure of the inhibitor, but common modes include competitive inhibition at binding sites or allosteric modulation that affects the protein's conformation.
The chemical structure of FLJ30851 inhibitors often features functional groups that enable selective binding to the target protein. These inhibitors may be developed through rational drug design, leveraging knowledge of the protein's structure, or through high-throughput screening of chemical libraries. Binding affinity, specificity, and the ability to cross cellular membranes are key considerations in the development of these inhibitors. Once bound, FLJ30851 inhibitors can stabilize inactive conformations of the protein or prevent its interaction with other molecular partners, leading to downstream effects on the cellular pathways it regulates. In research settings, these inhibitors are valuable tools for studying the biological role of FLJ30851 in different cell types and conditions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor, can alter chromatin structure and gene expression, potentially affecting FLJ30851 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor, can change DNA methylation status and gene expression, possibly affecting FLJ30851 expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor, can prevent degradation of proteins, potentially increasing the stability of FLJ30851 if it is regulated by the UPS. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Protein synthesis inhibitor, can impede the synthesis of FLJ30851. | ||||||
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 | 612847-09-3 | sc-202048 sc-202048A | 1 mg 5 mg | $208.00 $270.00 | 29 | |
Inhibits Akt, which is involved in various signaling pathways, potentially affecting processes that regulate FLJ30851. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor, can affect the ERK pathway which might be involved in the regulation of FLJ30851. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, can affect cell growth and protein synthesis, potentially impacting FLJ30851 levels. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA pump inhibitor, can lead to increased cytosolic calcium levels, possibly affecting FLJ30851 if it is calcium-regulated. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Glycolysis inhibitor, can alter energy metabolism, potentially affecting cellular processes regulating FLJ30851. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Lysosome inhibitor, can prevent lysosomal degradation, potentially affecting the turnover of FLJ30851 if it is lysosome-regulated. | ||||||